|[September 19, 2013]
Huntington Hospital Offers New Treatment to Prolong Life in Prostate Cancer Patients
PASADENA, Calif. --(Business Wire)--
Memorial Hospital announced today that it is now offering a newly
approved therapy that prolongs life and offers much-needed pain relief
for men with advanced-stage prostate cancer.
"This drug is for patients who have exhausted all other treatment
options and whose prostate cancer has spread to the bones," says Kenneth
Lam, M.D., a radiation oncologist at Huntington Hospital. "It has shown
to not only extend life, but it improves the quality of life for
patients in the final weeks and months of their prostate cancer battle."
The drug, Xofigo (zo-FEEG-oh), is the first drug of its kind to be
approved by the Food and Drug Administration, and Huntington is one of
the first hospitals in the Los Angeles area to make it available. A form
of internal radiation, Xofigo is given through intravenous injection
once a month for six months. It moves quickly through the blood and
straight to the bone where it is absorbed like calcium ad specifically
targets tumor cells located next to bone tissue. There are few major
side effects, so the drug can even be used on older patients or patients
with multiple medical conditions. For many patients pain relief is
achieved in just a few days.
"Dr. Lam has been on the forefront of prostate cancer treatment for many
years," said Paula Verrette, M.D., senior vice president of quality and
physician services at Huntington Hospital. "He is dedicated to ensuring
that our patients receive the highest level of care available, and his
introduction of this drug for our patients is just the latest example of
his leadership in this area."
With 240,000 new cases diagnosed yearly, prostate cancer is among the
most common cancers affecting men in the United States. It is the second
leading cause of cancer-related deaths in U.S. men, with an estimated
30,000 deaths due to prostate cancer expected to occur in 2013 alone.
The Prostate Cancer Program at Huntington Hospital provides advanced
screening, diagnostic, surgical and radiation oncology services to
individuals with prostate cancer. It is part of the hospital's Cancer
Center that delivers state-of-the-art diagnostic capabilities and
leading-edge treatment options as well as care coordination and
emotional support services to patients with a cancer diagnosis.
Huntington Memorial Hospital is a 625-bed not-for-profit
hospital located in Pasadena, California. Huntington Hospital has been
ranked nationally by U.S. News and World Report in two
specialties and was named among the top hospitals in California.
Renowned for its programs in neurosciences, cardiovascular services and
cancer care, Huntington Hospital is an active teaching hospital
with graduate medical education programs in internal medicine and
general surgery. Consistent with its mission the hospital provides
millions of dollars annually in charity care, benefits for vulnerable
populations, health research, education and training, and support
programs that may otherwise be absent from the community. For more
information, visit www.huntingtonhospital.com.
[ Back To Technology News's Homepage ]